This is the competing renewal application for a T32 program that has been supporting research training in the Duke GI Division since 1965. The goal of the program remains to train outstanding individuals with doctoral degrees (MD, PhD, or MD/PhD) to conduct independent investigation relevant to the basic mechanisms, treatment, and outcomes of gastrointestinal, pancreatic, and liver diseases. Since funding was last renewed in 2006, the program has graduated 4 MD researchers (2 men/2 women), all of whom are now full members of the Duke GI Division faculty. Each has already secured further research career development funding from NIH and/or foundations. Another 3 MD trainees (including an Asian American woman) will soon be completing T32 training support. All of these will also remain at Duke to continue training, and two of the three recently won research grants to support their continued career development. Another two MDs (including a woman) will enter the T32 program in July 2010. Two other MD trainees, including an African American woman, have been selected for enrollment in July 2011. During this renewal, the training program has been re-organized into 3 Tracks to more clearly delineate the training programs and faculty in our three areas of research excellence: basic science (Track I), clinical research (Track II) and outcomes research (Track III). It provides a unique opportunity for intensive training in techniques, concepts, principles, and attitudes which will permit our trainees to pursue a career in research into the basic mechanisms, treatments, and outcomes of GI/liver diseases. Physicians and Ph.D.s trained by our program will be optimally prepared to play key roles in translational research aimed at: 1) elucidating disease mechanisms using state of the art molecular approaches;2) gaining new clinical insights into the diagnosis and natural history of GI/liver diseases;3) development of new treatment approaches for GI and liver disorders;and 4) refining clinician practice and health delivery systems to optimize the positive impacts of new knowledge/treatments of GI and liver diseases. Our program's recent track record attests to its success at achieving these mile stones that are pre-requisites for advancing prevention, treatment, and cure of GI/liver diseases.

Public Health Relevance

Continued funding for this research training program is important because the program provides physicians and Ph.D. scientists with state-of-the-art research skills, as well as knowledge of the normal physiology and disease states of gastrointestinal (GI) tract and liver, that are vital for advancing the prevention, treatment, and eventual cure of GI/liver diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK007568-23
Application #
8521243
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Densmore, Christine L
Project Start
1988-07-01
Project End
2016-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
23
Fiscal Year
2013
Total Cost
$191,753
Indirect Cost
$14,096
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Patel, Yuval A; Muir, Andrew J (2016) Evaluation of New-Onset Ascites. JAMA 316:340-1
Patel, Yuval A; Muir, Andrew J (2016) Mechanisms of Ascites Development-Reply. JAMA 316:1829
Brown, Cristal L; Hammill, Bradley G; Qualls, Laura G et al. (2016) Significant Morbidity and Mortality Among Hospitalized End-Stage Liver Disease Patients in Medicare. J Pain Symptom Manage 52:412-419.e1
Machado, M V; Michelotti, G A; Pereira, T de Almeida et al. (2015) Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis. Gut 64:1148-57
Pourhoseini, Sahar; Seth, Ratanesh Kumar; Das, Suvarthi et al. (2015) Upregulation of miR21 and repression of Grhl3 by leptin mediates sinusoidal endothelial injury in experimental nonalcoholic steatohepatitis. PLoS One 10:e0116780
Karaca, Gamze; Xie, Guanhua; Moylan, Cynthia et al. (2015) Role of Fn14 in acute alcoholic steatohepatitis in mice. Am J Physiol Gastrointest Liver Physiol 308:G325-34
Bohinc, Brittany N; Michelotti, Gregory; Xie, Guanhua et al. (2014) Repair-related activation of hedgehog signaling in stromal cells promotes intrahepatic hypothyroidism. Endocrinology 155:4591-601
Karaca, Gamze; Swiderska-Syn, Marzena; Xie, Guanhua et al. (2014) TWEAK/Fn14 signaling is required for liver regeneration after partial hepatectomy in mice. PLoS One 9:e83987
Swiderska-Syn, M; Syn, W K; Xie, G et al. (2014) Myofibroblastic cells function as progenitors to regenerate murine livers after partial hepatectomy. Gut 63:1333-44
Chan, Isaac S; Guy, Cynthia D; Machado, Mariana V et al. (2014) Alcohol activates the hedgehog pathway and induces related procarcinogenic processes in the alcohol-preferring rat model of hepatocarcinogenesis. Alcohol Clin Exp Res 38:787-800

Showing the most recent 10 out of 51 publications